Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC.
Hamakawa Y, Agemi Y, Shiba A, Ikeda T, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Nakamura Y, Shimokawa T, Saigusa Y, Kobayashi N, Okamoto H, Kaneko T. Hamakawa Y, et al. Among authors: aga m. Cancer Med. 2023 Sep;12(17):17788-17797. doi: 10.1002/cam4.6405. Epub 2023 Aug 7. Cancer Med. 2023. PMID: 37548381 Free PMC article.
Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report.
Sawada H, Taniguchi Y, Iizuka S, Ikeda T, Aga M, Hamakawa Y, Miyazaki K, Misumi Y, Agemi Y, Nakamura Y, Maeda K, Shimokawa T, Okamoto H. Sawada H, et al. Among authors: aga m. Case Rep Oncol. 2023 Dec 12;16(1):1558-1567. doi: 10.1159/000534549. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 38089732 Free PMC article.
Optimal Therapy for Postoperative Recurrence: Does Salvage Radiation Work for Locoregional Recurrence?
Taniguchi Y, Shigenobu T, Hayashi A, Hirahara A, Ito K, Shinohara H, Shiba A, Higashi Y, Tabuchi Y, Suzuki T, Aga M, Hamakawa Y, Miyazaki K, Sato M, Misumi Y, Agemi Y, Nakamura Y, Shimokawa T, Odagiri K, Yoshizu A, Okamoto H. Taniguchi Y, et al. Among authors: aga m. Anticancer Res. 2024 Dec;44(12):5541-5549. doi: 10.21873/anticanres.17380. Anticancer Res. 2024. PMID: 39626937
105 results